NCT03772275Recruiting
Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure
Clinical and Economical Study Evaluating the Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure
Source: ClinicalTrials.gov · Last updated 11 Dec 2018 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Clinical and Economic study of some new biomarkers in chronic heart failure.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 7 Dec 2018
- Start date
- 1 Oct 2018
- Primary completion date
- Oct 2026
- Lead sponsor
- Sherief Abd-Elsalam
- Diseases
- Heart failure
- NCT number
- NCT03772275
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Oct 2018 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Liver or renal dysfunction. --DM
Who the study is looking for
- NYHA-Class II-IV
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sherief Abd-Elsalam Coordinator of this site? Confirm its status | Tanta | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.